Alkermes (ALKS) Stock
Alkermes (ALKS) closed at $47.03 on Nov 13, 2026; its Tenet Score is 37 of 100 against 297 Healthcare peers.
6 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $47.03
- Nov 13, 2026
- Market cap
- $7.9B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 27.00 – 55.67
- low → high · as of close, Nov 13, 2026
- Tenet Score
- 37/100
- Weak · 297 Healthcare peers
Industry: Drugs
Alkermes plc scores 37/100. Weak. Financial health is the soft spot versus 297 Healthcare peers.
Tenet Score · vs sector
n=297Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ~ Piotroski F-Score
- ✕ Munger Compounders
- ✕ Magic Formula
- ✕ Graham Defensive
- ✕ Quality Compounder
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products inc…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Krystal Biotech IncKRYS | 66 | $9.0B |
| Protagonist Therapeutics IncPTGX | 65 | $8.5B |
| Corcept Therapeutics IncCORT | 54 | $8.0B |
| Rhythm Pharmaceuticals Inc.RYTM | 37 | $8.0B |
| Cytokinetics IncCYTK | 34 | $7.8B |
| Kiniksa Pharmaceuticals International Plc.KNSA | 55 | $7.6B |
| Axsome Therapeutics IncAXSM | 30 | $7.5B |
| Amneal Pharmaceuticals IncAMRX | 38 | $7.4B |
| Oruka Therapeutics Inc.ORKA | 54 | $7.1B |
| Twist Bioscience CorpTWST | 39 | $7.0B |
Common questions
What sector and industry is Alkermes in?
Alkermes is in the Healthcare sector and the Drugs industry.
What is Alkermes' Tenet Score?
Alkermes' Tenet Score is 37 out of 100, ranked against 297 Healthcare peers as of Nov 13, 2026.




